Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Apr;185(4):1275-1281.
doi: 10.1002/ajmg.a.62098. Epub 2021 Feb 2.

Ophthalmic phenotypes associated with biallelic loss-of-function PCDH12 variants

Francesca Mattioli  1 , Norine Voisin  1 , Eglė Preikšaitienė  2 , Irina Kozlovskaja  3 , Vaidutis Kučinskas  2 , Alexandre Reymond  1
Affiliations
Case Reports

Ophthalmic phenotypes associated with biallelic loss-of-function PCDH12 variants

Francesca Mattioli et al. Am J Med Genet A. 2021 Apr.

Abstract

Individuals carrying biallelic loss-of-function mutations in PCDH12 have been reported with three different conditions: the diencephalic-mesencephalic junction dysplasia syndrome 1 (DMJDS1), a disorder characterized by global developmental delay, microcephaly, dystonia, and a midbrain malformation at the diencephalic-mesencephalic junction; cerebral palsy combined with a neurodevelopmental disorder; and cerebellar ataxia with retinopathy. We report an additional patient carrying a homozygous PCDH12 frameshift, whose anamnesis combines the most recurrent DMJDS1 clinical features, that is, global developmental delay, microcephaly, and ataxia, with exudative vitreoretinopathy. This case and previously published DMJDS1 patients presenting with nonspecific visual impairments and ophthalmic disorders suggest that ophthalmic alterations are an integral part of clinical features associated with PCDH12 loss-of-function.

Keywords: PCDH12; diencephalic-mesencephalic junction dysplasia syndrome; retinopathy.

PubMed Disclaimer

References

REFERENCES

    1. Aran, A., Rosenfeld, N., Jaron, R., Renbaum, P., Zuckerman, S., Fridman, H., Zeligson, S., Segel, R., Kohn, Y., Kamal, L., Kanaan, M., Segev, Y., Mazaki, E., Rabinowitz, R., Shen, O., Lee, M., Walsh, T., King, M. C., Gulsuner, S., & Levy-Lahad, E. (2016). Loss of function of PCDH12 underlies recessive microcephaly mimicking intrauterine infection. Neurology, 86(21), 2016-2024. https://doi.org/10.1212/WNL.0000000000002704
    1. Bouillot, S., Tillet, E., Carmona, G., Prandini, M.-H., Gauchez, A.-S., Hoffmann, P., Alfaidy, N., Cand, F., & Huber, P. (2011). Protocadherin-12 cleavage is a regulated process mediated by ADAM10 protein: Evidence of shedding up-regulation in pre-eclampsia. The Journal of Biological Chemistry, 286(17), 15195-15204. https://doi.org/10.1074/jbc.M111.230045
    1. Desvignes, J.-P., Bartoli, M., Delague, V., Krahn, M., Miltgen, M., Béroud, C., & Salgado, D. (2018). VarAFT: A variant annotation and filtration system for human next generation sequencing data. Nucleic Acids Research, 46(W1), W545-W553. https://doi.org/10.1093/nar/gky471
    1. Gilmour, D. F. (2015). Familial exudative vitreoretinopathy and related retinopathies. Eye, 29(1), 1-14. https://doi.org/10.1038/eye.2014.70
    1. Guemez-Gamboa, A., Çağlayan, A. O., Stanley, V., Gregor, A., Zaki, M. S., Saleem, S. N., Musaev, D., McEvoy-Venneri, J., Belandres, D., Akizu, N., Silhavy, J. L., Schroth, J., Rosti, R. O., Copeland, B., Lewis, S. M., Fang, R., Issa, M. Y., Per, H., Gumus, H., … Gleeson, J. G. (2018). Loss of Protocadherin-12 leads to diencephalic-mesencephalic junction dysplasia syndrome. Annals of Neurology, 84(5), 638-647. https://doi.org/10.1002/ana.25327

Publication types

MeSH terms

LinkOut - more resources